BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12725068)

  • 21. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells.
    Elattar TM; Virji AS
    Anticancer Res; 1999; 19(1A):365-8. PubMed ID: 10226568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta.
    Turley JM; Funakoshi S; Ruscetti FW; Kasper J; Murphy WJ; Longo DL; Birchenall-Roberts MC
    Cell Growth Differ; 1995 Jun; 6(6):655-63. PubMed ID: 7669719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-tocopherol succinate inhibits growth of gastric cancer cells in vitro.
    Rose AT; McFadden DW
    J Surg Res; 2001 Jan; 95(1):19-22. PubMed ID: 11120630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin E succinate inhibits colon cancer liver metastases.
    Barnett KT; Fokum FD; Malafa MP
    J Surg Res; 2002 Aug; 106(2):292-8. PubMed ID: 12175981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 2002; 43(2):227-36. PubMed ID: 12588702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro.
    Ripoll EA; Rama BN; Webber MM
    J Urol; 1986 Aug; 136(2):529-31. PubMed ID: 3735528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
    Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
    Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the effects of vitamin E on neuroblastoma N1E 115.
    Slack R; Proulx P
    Nutr Cancer; 1989; 12(1):75-82. PubMed ID: 2710649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
    Ni J; Pang ST; Yeh S
    Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
    Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roles of mitochondria in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells].
    Wu K; Li GC; Zhao Y; Zhang XH
    Wei Sheng Yan Jiu; 2005 Jan; 34(1):58-60. PubMed ID: 15862025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RRR-alpha-tocopheryl succinate inhibition of lectin-induced T cell proliferation.
    Kline K; Sanders BG
    Nutr Cancer; 1993; 19(3):241-52. PubMed ID: 8346073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells.
    Turley JM; Fu T; Ruscetti FW; Mikovits JA; Bertolette DC; Birchenall-Roberts MC
    Cancer Res; 1997 Mar; 57(5):881-90. PubMed ID: 9041190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro.
    Kline K; Cochran GS; Sanders BG
    Nutr Cancer; 1990; 14(1):27-41. PubMed ID: 2367234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.
    Ni J; Chen M; Zhang Y; Li R; Huang J; Yeh S
    Biochem Biophys Res Commun; 2003 Jan; 300(2):357-63. PubMed ID: 12504091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effective molecular form of alpha-tocopheryl succinate in inducing apoptosis of SGC-7901 cells].
    Li HW; Zhao L; Wu K
    Wei Sheng Yan Jiu; 2005 Mar; 34(2):149-51. PubMed ID: 15952647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of murine EL-4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1996; 25(2):137-49. PubMed ID: 8710683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
    Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
    Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.